Range of suitable clients: CDEC mentioned the uncertainty in the number of patients with moderately serious to serious hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical experts consulted by CADTH indicated that some sufferers who're classified as getting moderate or average condition may have a severe bleeding phenotype, which https://hemgenix84826.blogzet.com/a-secret-weapon-for-hemgenix-50590151